Heterozygous alterations of TNFRSF13B/TACI in tonsillar hypertrophy and sarcoidosis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Speletas, Matthaios ^a   Salzer, Ulrich ^b   Florou, Zoe ^a   Petinaki, Efthimia ^a   Daniil, Zoe ^c   Bardaka, Fotini ^c   Gourgoulianis, Konstantinos I ^c   Skoulakis, Charalampos ^c   Germenis, Anastasios E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TNFRSF13B PROTEIN, HUMAN;

ADENOTONSILLAR HYPERTROPHY; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DYSPHAGIA; FEMALE; HAEMOPHILUS INFLUENZAE; HETEROZYGOTE; HUMAN; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MOUTH BREATHING; MUTATIONAL ANALYSIS; NEUROFIBROMATOSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SARCOIDOSIS; SLEEP DISORDERED BREATHING; SNORING; THORAX RADIOGRAPHY; ADULT; AGED; COMMON VARIABLE IMMUNODEFICIENCY; GENE FREQUENCY; GENETICS; HYPERTROPHY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MUTATION; PALATINE TONSIL; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENE FREQUENCY; HETEROZYGOTE; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED; MUTATION; PALATINE TONSIL; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOIDOSIS; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; YOUNG ADULT;

EID: 84881494681     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/532437     Document Type: Article

References (20)

1. Castigli E., Wilson S. A., Garibyan L., Rachid R., Bonilla F., Schneider L., Geha R. S., TACI is mutant in common variable immunodeficiency and IgA deficiency. Nature Genetics 2005 37 8 829 834 2-s2.0-23044463627 10.1038/ng1601 (Pubitemid 41077108)
2. Salzer U., Chapel H. M., Webster A. D. B., Pan-Hammarström Q., Schmitt-Graeff A., Schlesier M., Peter H. H., Rockstroh J. K., Schneider P., Schäffer A. A., Hammarström L., Grimbacher B., Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nature Genetics 2005 37 8 820 828 2-s2.0-23044443492 10.1038/ng1600 (Pubitemid 41077107)
3. Salzer U., Bacchelli C., Buckridge S., Pan-Hammarström Q., Jennings S., Lougaris V., Bergbreiter A., Hagena T., Birmelin J., Plebani A., Webster A. D. B., Peter H.-H., Suez D., Chapel H., McLean-Tooke A., Spickett G. P., Anover-Sombke S., Ochs H. D., Urschel S., Belohradsky B. H., Ugrinovic S., Kumararatne D. S., Lawrence T. C., Holm A. M., Franco J. L., Schulze I., Schneider P., Gertz E. M., Schaffer A. A., Hammarström L., Thrasher A. J., Gaspar H. B., Grimbacher B., Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009 113 9 1967 1976 2-s2.0-61849167388 10.1182/blood-2008-02-141937
4. Speletas M., Mamara A., Papadopoulou-Alataki E., Iordanakis G., Liadaki K., Bardaka F., Kanariou M., Germenis A. E., TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies. Journal of Clinical Immunology 2011 31 4 550 559 2-s2.0-80555135392 10.1007/s10875-011-9536-4
5. Garibyan L., Lobito A. A., Siegel R. M., Call M. E., Wucherpfennig K. W., Geha R. S., Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). Journal of Clinical Investigation 2007 117 6 1550 1557 2-s2.0-34249909831 10.1172/JCI31023 (Pubitemid 46871339)
6. Bacchelli C., Buckland K. F., Buckridge S., Salzer U., Schneider P., Thrasher A. J., Gaspar H. B., The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. Journal of Allergy and Clinical Immunology 2011 127 5 1253 1259 2-s2.0-79955589621 10.1016/j.jaci.2011.02.037
7. Kumar A., Teuber S. S., Gershwin M. E., Current perspectives on primary immunodeficiency diseases. Clinical and Developmental Immunology 2006 13 2-4 223 259 2-s2.0-33845641138 10.1080/17402520600800705 (Pubitemid 44950040)
8. Fried A. J., Bonilla F. A., Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clinical Microbiology Reviews 2009 22 3 396 414 2-s2.0-67651004925 10.1128/CMR.00001-09
9. Busse P. J., Farzan S., Cunningham-Rundles C., Pulmonary complications of common variable immunodeficiency. Annals of Allergy, Asthma and Immunology 2007 98 1 1 8 2-s2.0-33846201213 (Pubitemid 46106152)
10. Seshasayee D., Valdez P., Yan M., Dixit V. M., Tumas D., Grewal I. S., Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 2003 18 2 279 288 2-s2.0-0037332043 10.1016/S1074-7613(03)00025-6 (Pubitemid 36263002)
11. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., Tumas D., Grewal I. S., Dixit V. M., Activation and accumulation of B cells in TACI-deficient mice. Nature Immunology 2001 2 7 638 643 2-s2.0-0034919939 10.1038/89790 (Pubitemid 32677632)
12. Salzer U., Birmelin J., Bacchelli C., Witte T., Buchegger-Podbielski U., Buckridge S., Rzepka R., Gaspar H. B., Thrasher A. J., Schmidt R. E., Melchers I., Grimbacher B., Sequence analysis of TNFRSF13b, encoding TACI, in patients with systemic lupus erythematosus. Journal of Clinical Immunology 2007 27 4 372 377 2-s2.0-34250216415 10.1007/s10875-007-9094-y (Pubitemid 46906662)
13. Liadaki K., Petinaki E., Skoulakis C., Tsirevelou P., Klapsa D., Germenis A. E., Speletas M., Toll-like receptor 4 gene (TLR4), but not TLR2, polymorphisms modify the risk of tonsillar disease due to streptococcus pyogenes and haemophilus influenzae. Clinical and Vaccine Immunology 2011 18 2 217 222 2-s2.0-79551479872 10.1128/CVI.00460-10
14. Mohammadi J., Liu C., Aghamohammadi A., Bergbreiter A., Du L., Lu J., Rezaei N., Amirzargar A. A., Moin M., Salzer U., Pan-Hammarström Q., Hammarström L., Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. Journal of Clinical Immunology 2009 29 6 777 785 2-s2.0-72849116620 10.1007/s10875-009-9317-5
15. Lindroos R., Bacteriology of the tonsil core in recurrent tonsillitis and tonsillar hyperplasia-a short review. Acta Oto-Laryngologica, Supplement 2000 120 543 206 208 2-s2.0-0034353568 (Pubitemid 34098625)
16. van Staaij B. K., van den Akker E. H., De Haas Van Dorsser E. H. M., Fleer A., Hoes A. W., Schilder A. G. M., Does the tonsillar surface flora differ in children with and without tonsillar disease? Acta Oto-Laryngologica 2003 123 7 873 878 2-s2.0-0141637132 10.1080/00016480310000395 (Pubitemid 37222705)
17. Aniansson G., Alm B., Andersson B., Larrson P., Nylen O., Peterson H., Rigner P., Svanborg M., Svanborg C., Nasopharyngeal colonization during the first year of life. Journal of Infectious Diseases 1992 165 supplement 1 S38 S42 2-s2.0-0026632872
18. Sussine A., Tazi A., Feuillet S., Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS ONE 2012 7 8 e43588
19. Barroeta Seijas A. B., Graziani S., Cancrini C., The impact of TACI mutations: from hypogammaglobulinemia in infancy to autoimmunity in adulthood. International Journal of Immunopathology and Pharmacology 2012 25 2 407 414
20. Saenz-Cuesta M., Martínez-Pomar N., de Gracia J., TACI mutation in Good's Syndrome: in search of a genetic basis. Clinical Immunology 2012 145 1 27 30